Allograft-tissue company reports increased revenues.

2004 MAR 25 - (NewsRx.com & NewsRx.net) -- LifeCell Corp. (LIFC), a company focused on development and commercialization of products made from human (allograft) tissue for use in reconstructive, urogynecologic, and orthopedic surgical procedures, reported financial results for its fourth quarter and full year ended December 31, 2003.

Total revenues for the fourth quarter were $11.1 million as compared to $9.3 million for the fourth quarter of 2002. Product revenues of $10.7 million for the quarter were 21% above the $8.9 million reported for the same period in 2002. The increase in product revenue was primarily due to a significant increase in demand for the company's …